Stock listing
NASDAQ:EGLT Egalet Corporation Stock
Follow Egalet Corporation into a list and get an email when it puts out news.
Delisted NASDAQ:EGLT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:EGLT
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Where Egalet Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:EGLT · This page · Delisted | NASDAQ | United States | USD |
| NASDAQ:EGLTQ · Delisted | NASDAQ | United States | USD |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jean-François Formela Other companies: Korro Bio, Inc. (Co-Founder & Director · Since at least Nov 3, 2023); ImageneBio, Inc. (Director · Mar 25, 2021 – Jun 7, 2024 · Past); Translate Bio Inc (Director · Jun 27, 2018 – Sep 14, 2021 · Past); Spero Therapeutics, Inc. (Director · Nov 1, 2017 – Aug 17, 2021 · Past); Intellia Therapeutics, Inc. (Director · May 5, 2016 – Jun 14, 2022 · Past); Oruka Therapeutics, Inc. (Director · Feb 10, 2012 – Oct 22, 2012 · Past); Horizon Pharma PLC (Director · Jul 28, 2011 – Mar 2, 2012 · Past) | Director · Feb 5, 2014 – Feb 11, 2014 · Past |
| Matt Pauls Other companies: Palvella Therapeutics, Inc. (Director · Since at least Jun 29, 2026); Pelthos Therapeutics Inc. (Director · Since at least Jul 1, 2025); Soleno Therapeutics, Inc. (Director · Since at least Aug 15, 2023); Savara, Inc. (CHIEF EXECUTIVE OFFICER, Director · Since at least Oct 29, 2015); Strongbridge Biopharma plc (President & CEO, Director · Jan 1, 2018 – Feb 20, 2019 · Past) | Director · Jan 31, 2019 – May 20, 2020 · Past |
| Barbara Carlin | Chief Accounting Officer · Mar 6, 2018 – Jan 31, 2019 · Past |
| Joe McInnis | Director · Jan 31, 2019 – May 20, 2020 · Past |
| Luke Duster | Director · Jan 31, 2019 – Jun 18, 2019 · Past |
| Stan Musial | Chief Financial Officer · Feb 5, 2014 – Jun 13, 2018 · Past |
Log in to ask 6ix AI your own questions about Egalet Corporation.